Texas Oncology Foundation is ranked #1 of 10 medical research organizations in Dallas, TX, with an America's Best Score of 97 out of 100, based on its 2024 Form 990. It's named America's Best 2026.
Texas Oncology Foundation is a 501(c)(3) organization, classified under Medical Research (NTEE H30). Contributions are tax-deductible.
12377 Merit Dr Ste 700, Dallas, TX 75251-2241
Among the 14 scored medical research organizations in Dallas, Texas Oncology Foundation holds 32.8 months of operating reserves (peer median 23.1 months), runs a typical yearly surplus of 45.9% (peers: deficit of 4.2%), and has grown spending 32.3% a year (peers: grown spending 13.9% a year).
In fiscal year 2024 it reported $2,112,896 in revenue and $1,246,175 in expenses, with contributions making up 107.0% of revenue.
Texas Oncology Foundation is organized exclusively for religious, charitable, scientific, literary, and educational purposes, including, for the purpose of making distributions to organizations that qualify as exempt organizations under section 501(c)(3) Of the internal revenue code of 1986 and the regulations promulgated thereunder, as presently constituted and hereafter amended.
Largest programs · fiscal year 2024
Patient Support: The Patient Assistance program is in place to assist those currently going through cancer treatment with additional living expenses they may have. An application process has been set in place to determine eligibility for financial assistance, based upon the applicant's current medical condition and financial need. We currently have active funds in 37 communities.$726,678 spent · 80.3% of program spending
Symposiums: Survive & Thrive Texas Oncology Foundation's signature cancer and caregiver programming, Survive and Thrive, marries the clinical aspects of cancer care with the non-clinical. At its core, Survive and Thrive is an educational intervention that aims to improve a cancer survivor's future wellness through health promotion education, community interaction and engagement, and reinforcement… Read more
Symposiums: Survive & Thrive Texas Oncology Foundation's signature cancer and caregiver programming, Survive and Thrive, marries the clinical aspects of cancer care with the non-clinical. At its core, Survive and Thrive is an educational intervention that aims to improve a cancer survivor's future wellness through health promotion education, community interaction and engagement, and reinforcement of post-treatment follow up. Originally implemented as in-person, one-day events, we were able to adapt the programming to a virtual platform when pandemic concerns warranted. Now, our in person symposiums and virtual camps webinars and support groups successfully connect those affected by cancer regardless of location. Through our in person symposiums and virtual camps and webinars, we can deliver pertinent medical information, valuable tools and emotional support to cancer survivors and their families. Over 7000 people have been reached through our Survive and Thrive program since 2016
$178,669 spent · 19.7% of program spending
Where each dollar went · fiscal year 2024
Of every dollar it spent, 73¢ went to programs, 16¢ to management and 11¢ to fundraising.
Programs $905,347
Management $203,617
Fundraising $137,211
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
73%
Meets
Compared with Dallas peers
Measure
This organization
Peer median
Operating reserves
32.8 mo
23.1 mo
Typical margin
+45.9%
−4.2%
Spending growth
+32.3% / yr
+13.9% / yr
Debt load
3.9%
7.8%
Peers: the 14 Dallas medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$2,112,896Fiscal year 2024
Expenses$1,246,175Fiscal year 2024
Total assets$3,549,379Fiscal year 2024
Total liabilities$138,959Fiscal year 2024
Fiscal year ending December2024
Revenue$2,112,896
Expenses$1,246,175
Net income$866,721
Net assets$3,410,420
Notable sources of revenue
Percent of total revenue
Contributions
$2,261,208
107.0%
Program services
$0
0.0%
Investment income
$57,041
2.7%
Other (net)
−$205,353
−9.7%
Assets / debt
Total assets
$3,549,379
Total liabilities
$138,959
Net assets
$3,410,420
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$1,254,018
Expenses$1,032,126
Net income$221,892
Net assets$2,613,080
Notable sources of revenue
Percent of total revenue
Contributions
$1,309,519
104.4%
Program services
$0
0.0%
Investment income
$52,612
4.2%
Other (net)
−$108,113
−8.6%
Assets / debt
Total assets
$2,711,305
Total liabilities
$98,225
Net assets
$2,613,080
Compensation
Officers and key employees
$177,740
Share of expenses
17.2%
Fiscal year ending December2022
Revenue$1,038,531
Expenses$711,928
Net income$326,603
Net assets$2,391,188
Notable sources of revenue
Percent of total revenue
Contributions
$1,049,309
101.0%
Program services
$0
0.0%
Investment income
$15,331
1.5%
Other (net)
−$26,109
−2.5%
Assets / debt
Total assets
$2,414,036
Total liabilities
$22,848
Net assets
$2,391,188
Compensation
Officers and key employees
$114,978
Share of expenses
16.2%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?